Immunogenicity and safety of the protein-based heterodimer booster vaccine for COVID-19

By | July 8, 2022
Researchers compared the immunogenicity and safety of the protein-based heterodimer vaccine (PHH-1V) and BNT162b2 COVID-19 vaccines.